CD73 Is Enriched in Cutaneous Carcinomas That Invade the Orbit

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• Basal cell carcinoma (BCC) is the most common skin cancer.
• Orbital invasion by BCC can necessitate extensive surgical treatment.
• Understanding molecular markers in BCC invasion is crucial for targeted therapies.

Purpose of the Study:

• To investigate the differential expression of CD73 in indolent nodular basal cell carcinomas versus those invading the orbit.
• To assess the potential of CD73 as a biomarker for BCC invasion into orbital tissues.

Main Methods:

• Immunohistochemical analysis of CD73 expression in 10 control specimens and 11 invasive BCCs.
• Quantitative assessment of CD73-positive cells per high-power field.
• Statistical comparison using dedicated software to determine significance.

Main Results:

• CD73 expression was significantly elevated in invasive BCCs (mean 6.53 cells/field) compared to nodular BCCs (mean 0.72 cells/field).
• The difference in CD73 expression between the two groups was statistically significant (p = 0.0002).

Conclusions:

• CD73 is notably enriched in basal cell carcinomas that invade the orbit.
• CD73 represents a potential therapeutic target for managing orbital cutaneous carcinomas.
• Targeting CD73 may reduce the need for orbital exenteration in affected patients.